Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma
Dufour, B.; Choquenet, C.; Revol, M.; Faure, G.; Jorest, R.
Annales d'Urologie 18(3): 193-195
1984
ISSN/ISBN: 0003-4401 PMID: 6084978 Document Number: 240564
Two random groups of sixty patients each were given an extract of pygeum africanum in one group, and a placebo in the other. The results highlight the placebo effect (50 per cent of cases), and that the extract provided an overall improvement in the functional symptoms. The differences between the two treatments were statistically significant for nocturnal frequency, difficulty in starting micturition, and incomplete emptying of the bladder.
Document emailed within 1 workday
Related Documents
Thieblot, L.; Berthelay, S.; Berthelay, J. 1971: Preventive and curative action of a bark extract from an African plant, Pygeum africanum, on experimental prostatic adenoma in rats Therapie 26(3): 575-580Clavert, A.; Cranz, C.; Riffaud, J.P.; Marquer, C.; Lacolle, J.Y.; Bollack, C. 1986: Effects of an extract of the bark of Pygeum africanum (V.1326) on prostatic secretions in the rat and in man Annales D'urologie 20(5): 341-343
Vinarov, A.Z.; Aliaev, I.G.; Apolikhin, O.I.; Mazo, E.B.; Darenkov, S.P.; Demidko, I.L.; Lokshin, K.L.; Medvedev, A.A.; Permiakova, O.V.; Spivak, L.G.; Shkol'nikov, M.E. 2010: Results of three-year clinical study of prostamol uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression Urologiia 6: 3-10
Bauer, H.W.; Casarosa, C.; Cosci, M.; Fratta, M.; Blessmann, G. 1999: Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study MMW Fortschritte der Medizin 141(25): 62
Vinarov, A.Z.; Aliaev, I.G.; Lokshin, K.L. 2009: Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma Urologiia 1: 84; 86-87
Kondás, J.; Philipp, V.; Diószeghy, G. 1997: Sabal serrulata extract in the management of symptoms of prostatic hypertrophy Orvosi Hetilap 138(7): 419-421
Champault, G.; Bonnard, A.M.; Cauquil, J.; Patel, J.C. 1984: Medical treatment of prostatic adenoma. Controlled trial: PA 109 vs placebo in 110 patients Annales d'Urologie 18(6): 407-410
Pasechnikov, A.P. 1976: Dignosis of functional disorders of the lower urinary tract in prostatic adenoma Klinicheskaia Khirurgiia 00(9): 51-53
You, Y.; Cheng, G. 1997: Determination of docosyl ferulate in extract of Pygeum africanton Hook. by high performance liquid chromatography (HPLC) Se Pu 15(3): 259-260
Schneider, H.J.; Honold, E.; Masuhr, T. 1995: Treatment of benign prostatic hyperplasia. Results of a treatment study with the phytogenic combination of Sabal extract WS 1473 and Urtica extract WS 1031 in urologic specialty practices Fortschritte der Medizin 113(3): 37-40
Choi, S.Young.; Hong, J.Yeon.; Ko, E.Jung.; Kim, B.Joon.; Hong, S-Woon.; Lim, M.Hyoung.; Yeon, S.Hum.; Son, R.Ho. 2018: Protective effects of fermented honeybush (Cyclopia intermedia) extract (HU-018) against skin aging: a randomized, double-blinded, placebo-controlled study Journal of Cosmetic and Laser Therapy 20(5): 313-318
Alver, J.E.; Mooppan, U.M.; Kester, R.R.; Gintautas, J.; Abadir, A.R.; Kim, H. 1989: The effects of the alpha 1-adrenergic antagonists terazosin and phentolamine on prostatic adenoma and urethra in vitro Proceedings of the Western Pharmacology Society 32: 317-325
Lopatkin, N.A.; Sivkov, A.V.; Medvedev, A.A.; Walter, K.; Schlefke, S.; Avdeĭchuk, I.I.; Golubev, G.V.; Mel'nik, K.P.; Elenberger, N.A.; Engelman, U. 2006: Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial Urologiia 2006(2): 12 14-9
Buĭlov, V.M. 1984: X-ray television study in the excretory urography of patients with prostatic adenoma Vestnik Rentgenologii i Radiologii 1984(1): 79-82
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Macìas, G.; Merki-Feld, G.S.; Parke, S.; Mellinger, U.; Serrani, M. 2013: Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY Ii study Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 33(6): 591-596
Mastropasqua, F.; Totaro, P.; Massari, F.; Pitzalis, M.V.; Rizzon, P. 1998: Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms Cardiologia 43(6): 617-623
Pushkar', D.Iu.; Loran, O.B.; Petrov, S.B.; Kogan, M.I.; Zhuravlev, V.N. 2008: Efficacy and safety of revocarin in patients with impaired micturition due to prostatic adenoma. An open non-comparative study: results of a multicenter trial Urologiia 2008(1): 23 25-6
Aliaev, I.G.; Vinarov, A.Z.; Demidko, I.L.; Spivak, L.G. 2013: The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia Urologiia 4: 32-36
Yu, H.J.; Chiu, T.Y.; Lai, M.K. 1995: Therapeutic effects of finasteride in benign prostatic hyperplasia: a randomized double-blind controlled trial Journal of the Formosan Medical Association 94(1-2): 37-41